Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-09-29
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
562563, 548496, A61K 3805, C07K 5072
Patent
active
058146113
ABSTRACT:
A pharmaceutical preparation for the therapy of immune deficiency conditions comprising an active principle--a peptide of the structure: H--L--Glu--L--Trp--OH and a pharmaceutically acceptable vehicle.
REFERENCES:
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4473554 (1984-09-01), Umezawa et al.
patent: 4699898 (1987-10-01), Gottlieb
patent: 4751216 (1988-06-01), Gottlieb
patent: 5106616 (1992-04-01), McAnalley et al.
Declaration of John S. Sundsmo.
N.S. Gee and A.J. Kenny (1987) Biochem. J. 246:97-102. Proteins of the kidney microvillar membranes.
G. Belokrylov et al. (1986) Eksp. Biol. Medit. 102:51-53. Ability Of Some Amino Acids Incorporated Into Protein To Stimulate The Thymus-Dependent Immune Response.
G. R. Pettit (1975) Synthetic Peptides, vol. 3, Academic Press, New York, New York, pp. 130, 134, 143, 424, 427, 429, 434.
H. Sievertsson et al. (1971) Journal of Medicinal Chemistry, 15(1):8-11. Synthesis of Di-and Tripeptides and Assay in Vivo for Activity in the Thyrotrol Releasing Hormone and the Luteinizing Releasing Hormone Systems.
Chem. Abstr. 116(17) 171986u (1990).
Chem. Abstr. 111(17) 146389r (1989).
Sandstrom et al. (1987) Drugs 34:372-390. Antiviral Therapy in AIDS Clinical Pharmacological Properties and Therapeutic Experience to Date.
Remington's Pharmaceutical Sciences, 1980, pp. 996-997, 1465-1469, 1553-1557.
Jaroff, Time May 23, 1988, pp. 56-64. Stop That Germ|.
ASM News vol. 56 1990, p. 368.
Basmajian et al. (1982) Stedman's Medical Dictionary p. 1139.
Khavinson Vladimir Khatskelevich
Morozov Vyacheslav Grigorievich
Cytoven J.V.
Nucker Christine M.
Prickril Benet
LandOfFree
Pharmaceutical for the therapy of immune deficiency conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical for the therapy of immune deficiency conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical for the therapy of immune deficiency conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686344